文献速递重症综合管理与镇静镇痛心脑血管急症

顾问式中心辐射远程神经重症监护网络中的医疗决策与流程指标

Medical Decision-Making and Process Measures in a Consultative Hub-and-Spoke Teleneurocritical Care Network.
PubMed 文献 · Neurocrit Care · 2026-01-08
一句话结论在缺乏专职神经重症监护的医院,远程神经重症监护会诊为71.8%的三级医院患者建议了评估或管理变更,社区医院患者极少需要转诊。

该前瞻性观察研究纳入两个远程神经重症监护(TeleNCC)队列。三级医院医疗决策队列(n=123)中,TeleNCC顾问为71.8%的患者建议了评估和管理变更,涉及神经影像、神经监测、药物启动/调整、手术管理和重症降阶梯,且会诊常不需要视频评估。社区医院流程指标队列(n=1493)中,会诊时长因站点而异,转诊至三级医院罕见(10家医院中9家为0-9.2%),但蛛网膜下腔出血患者转诊更频繁(38.5%;p<0.001)。社区医院提供者在TeleNCC指导下评估了47例脑死亡,单纯临床标准评估的26例中16例(61.5%)符合标准,附加辅助检查评估的21例中16例(76.2%)符合标准。作者认为这些观察性队列显示TeleNCC在不同医疗场景中的多功能性和效率,但需要干预性研究评估其对临床结局的影响。

要点

  • 三级医院医疗决策队列(n=123)中,TeleNCC顾问为71.8%的患者建议了评估和管理变更,包括神经影像、神经监测、药物启动/调整、手术管理和重症降阶梯。
  • 社区医院流程指标队列(n=1493)中,转诊至三级医院罕见(10家医院中9家为0-9.2%),但蛛网膜下腔出血患者转诊更频繁(38.5%;p<0.001)。
  • 社区医院提供者在TeleNCC指导下评估47例脑死亡,单纯临床标准评估的26例中16例(61.5%)符合标准,附加辅助检查评估的21例中16例(76.2%)符合标准。
  • TeleNCC会诊常不需要视频评估。
  • 作者认为这些观察性队列显示TeleNCC在不同医疗场景中的多功能性和效率,但需要干预性研究评估其对临床结局的影响。

适用人群与场景

  • 三级医院医疗决策队列:一家有神经外科、神经内科和重症监护但无专职神经重症监护的三级医院患者(n=123)。
  • 社区医院流程指标队列:十家缺乏现场神经内科支持的社区医院患者(n=1493)。

研究设计与关键结果

  • 研究类型:前瞻性观察研究,两个TeleNCC队列。
  • 三级医院医疗决策队列(n=123):TeleNCC顾问为71.8%的患者建议了评估和管理变更,包括神经影像、神经监测、药物启动/调整、手术管理和重症降阶梯;会诊常不需要视频评估。
  • 社区医院流程指标队列(n=1493):会诊时长因站点而异;转诊至三级医院罕见(10家医院中9家为0-9.2%),但蛛网膜下腔出血患者转诊更频繁(38.5%;p<0.001),高于中毒代谢性/系统性脑病、缺氧缺血性脑病或其他脑血管疾病患者。
  • 社区医院提供者在TeleNCC指导下评估47例脑死亡:单纯临床标准评估的26例中16例(61.5%)符合标准;附加辅助检查评估的21例中16例(76.2%)符合标准。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:作者指出需要干预性研究评估TeleNCC对临床结局的影响。

对床旁实践的改变

  • 在无专职神经重症监护的三级医院,TeleNCC会诊可为大多数患者(71.8%)提供评估和管理变更建议,且常不需要视频评估。
  • 在缺乏现场神经内科支持的社区医院,TeleNCC会诊作为初始神经评估时,患者极少需要转诊至三级医院(10家医院中9家为0-9.2%),但蛛网膜下腔出血患者转诊更频繁(38.5%;p<0.001)。
  • 社区医院提供者可在TeleNCC指导下进行脑死亡评估,单纯临床标准评估的26例中16例(61.5%)符合标准,附加辅助检查评估的21例中16例(76.2%)符合标准。
  • 作者认为这些观察性队列显示TeleNCC在不同医疗场景中的多功能性和效率,但需要干预性研究评估其对临床结局的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Teleneurocritical care (TeleNCC) aims to project expertise to hospitals lacking dedicated neurocritical care. However, its influence on clinical care remains underexplored.

METHODS: We prospectively studied two TeleNCC cohorts. Within a tertiary care medical decision-making cohort, TeleNCC consultants documented recommended changes in prespecified aspects of evaluation and management for patients at a tertiary care hospital with neurosurgery, neurology, and critical care but without dedicated neurocritical care. In a separate community process measure cohort, TeleNCC consultants documented prespecified process measures (consultation duration, transfer to tertiary care versus local patient retention, and approaches to brain death determination) for patients across ten community hospitals lacking on-site neurology support. Differences were evaluated by site and diagnosis.

RESULTS: Within the tertiary care medical decision-making cohort (n = 123), TeleNCC consultants recommended changes in evaluation and management for 71.8% of patients, including neuroimaging, neuromonitoring, medication initiation/adjustment, operative management, and de-escalation from critical care. TeleNCC consultations often did not require video evaluation. Within the community process measure cohort (n = 1493), consultation duration varied by site. Tertiary care transfer was rare (0-9.2% among 9 of 10 hospitals), although patients with subarachnoid hemorrhage (SAH) were transferred more frequently (38.5%; p < 0.001) than patients with toxic-metabolic/systemic encephalopathy, hypoxic-ischemic encephalopathy, or other cerebrovascular disorders. Community hospital providers evaluated 47 patients for brain death under TeleNCC guidance; 16 (61.5%) of 26 patients evaluated by clinical criteria alone met criteria, as well as 16 (76.2%) of 21 patients evaluated via additional ancillary testing.

CONCLUSIONS: For patients at a tertiary care hospital, TeleNCC consultants recommended changes in medical decision-making for the vast majority of patients, whereas community hospital patients receiving TeleNCC consultation as their initial neurologic evaluation rarely required transfer to tertiary care, despite complex conditions, including suspected brain death. These observational cohorts demonstrate the versatility and efficiency of TeleNCC across care settings, although interventional studies are needed to evaluate the impact of TeleNCC on clinical outcomes.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Bitar R, Whitney C, Matiello M, et al. Medical Decision-Making and Process Measures in a Consultative Hub-and-Spoke Teleneurocritical Care Network. Neurocrit Care. 2026. PMID: 41507671. doi:10.1007/s12028-025-02420-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。